Bulk Drug Substances (Active Pharmaceutical Ingredients) and Intermediates for the Pharmaceutical Industry 2026

Language:
Japanese
Product Code No:
C68112300
Issued In:
2026/09
#of Pages:
181
Publication Cycle:
  
Format:
PDF

Price

150,000 yen ($941.09)
(excluding consumption tax)
300,000 yen ($1,882.18)
(excluding consumption tax)
450,000 yen ($2,823.26)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 159.39 yen , 2026/11/19 Japan)
*Scope of Each License Type

Coverage: (Product/service)

Bulk drug substances (active pharmaceutical ingredients) and intermediate for pharmaceuticals

Research Target:

Manufacturers and suppliers of bulk drug substances and intermediate for pharmaceuticals

Research Content:

For 35 years, since the publication of the "Fine Chemicals Market" report in 1989, Yano Research Institute has analyzed bulk drug substances (BDS), active pharmaceutical ingredients (APIs), and intermediates for the pharmaceutical industry.
While continuing to discuss the overall domestic BDS, API, and intermediate market, this edition includes market trends and sizes, as well as trends among market participants and changes in the original equipment (OEM) market environment for low-molecular-weight APIs. 

TOC:

I. Trends in Market Trend Analysis of Bulk Drug Substances (Active Pharmaceutical Ingredients) and Intermediates for Pharmaceuticals

  1. Transition of Market Size of Bulk Drug Substances and Intermediates
  2. Trends in Bulk Drug Substance and Intermediate Manufacturers and Suppliers
  3. Problems and Challenges for Bulk Drug Substance and Intermediate Manufacturers and Suppliers
  4. Market Outlook of Bulk Drug Substances and Intermediates
  5. Estimated Market Size of Bulk Drug Substances and Intermediates (FY2026- FY2030)

II. Trend Analysis of Bulk Drug Substance and Intermediate Manufacturers and Suppliers

  1. Companies' Business Overview
  2. Recent Requests from Product Owners (Pharmaceutical Companies) to Contract Manufacturers
  3. R&D Trends
  4. Supply Chain Management (SCM) Centered on Production and Quality Management
  5. Sales Trends
  6. Current Market Assessment
  7. Future Market Strategies
  8. Promising Areas in the Bulk Drug Substance and Intermediate Business

III. Profiles of Bulk Drug Substance and Intermediate Manufacturers and Suppliers

  • AGC Inc.
  • UBE Corporation
  • KOA SHOJI HOLDINGS CO.,LTD.
  • KNC Laboratories Co., Ltd.
  • Kongo Chemical Co., Ltd.
  • SANYO FINE CO., LTD.
  • SHIRATORI PHARMACEUTICAL CO.LTD.
  • SUMITOMO CHEMICAL COMPANY, LIMITED
  • Daito Pharmaceutical Co., Ltd.
  • NARD Chemicals, Ltd./NARD Chemicals, Ltd.
  • Nissan Chemical Corporation.
  • Nitto, Inc.
  • NIPPON SHOKUBAI CO., LTD.
  • Nippon Bulk Yakuhin Co., Ltd.
  • Fukuzyu Pharmaceutical Co., Ltd.
  • Muromachi Chemicals Inc.

(Reference) A list of Market Participants

Price

150,000 yen ($941.09)
(excluding consumption tax)
300,000 yen ($1,882.18)
(excluding consumption tax)
450,000 yen ($2,823.26)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 159.39 yen , 2026/11/19 Japan)
*Scope of Each License Type